The UAE has become the second country to approve once-daily, oral pill - Lipfendra - to treat adults with elevated low-density lipoprotein (LDL-C) cholesterol, a leading risk factor for cardiovascular disease.
Making the announcement, the Emirates Drug Establishment (EDE) explained that Lipfendra can also treat "certain inherited conditions" as long as it is cleared by a healthcare professional.
It is said to expand treatment options for adults and improve their quality of life.
Patients are advised to maintain a balanced diet and regular physical activity alongside the treatment.
The move is part of efforts by the UAE to authorise innovative medicines and expand treatment options for adults.
UAE strongly condemns attacks by Houthi Group on Saudi civilian facilities
Etihad Airways, Etihad Rail to explore enhanced UAE air-rail transport integration
UAE allocates $8 million to support Chad amid El Nino food crisis
UAE, Syrian Presidents discuss stronger economic and development ties
Sheikha Latifa honours Arab Media Award winners
H.H. Sheikh Mohammed reaffirms 'relations with Syria' during meeting with Al-Sharaa
Abu Dhabi streamlines holiday home regulatory process
Ahmad Al-Sharaa expresses confidence in Syria's revival at Arab Media Summit
